PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search
BNF Chapter
BNF Paragraph
Please select a BNF Chapter.
Search Results : Inflammatory bowel disease (Prednisolone - Inflammatory bowel disease)
Records returned : 10 (on 03 May 2024 at 02:13:08). Return to search results for ' Inflammatory bowel disease '.
Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
01.05.02
Non Formulary
Formulations :
- Foam enema
ASPH
RSCH
SASH
SABP
Primary Care
Important
Budesonide rectal foam is preferred.
Steroid safety considerations
01.05.02
06.03.02
Green
Formulations :
- Foam enema
ASPH
RSCH
SASH
SABP
Primary Care
Important
Steroid safety considerations
01.05.01
Green
Formulations :
- Gastro-resistant tablets
ASPH
RSCH
SASH
SABP
Primary Care
Important
Preferred
Prescribe by brand
Gastro-resistant tablets = Octasa or Salofalk are 1st line for new patients
Asacol tablets are non-formulary
Green
Formulations :
- Suppositories
ASPH
RSCH
SASH
SABP
Primary Care
Important
Prescribe by brand
Octasa, Salofalk, Pentasa
Green
Formulations :
- Enema
ASPH
RSCH
SASH
SABP
Primary Care
Important
Prescribe by brand
Pentasa / Salofalk enema
Green (see narrative)
Formulations :
- Modified release tablets
ASPH
RSCH
SASH
SABP
Primary Care
Important
Prescribe by brand
Mezevant XL
Reserve for patients with a high pill burden.
Green (see narrative)
Formulations :
- Granules (slow release)
- Modified release tablets
ASPH
RSCH
SASH
SABP
Primary Care
Important
Prescribe by brand
Pentasa modified-release tablets and granules for patients who require upper GI release.
08.02.01
Amber
Formulations :
- Oral suspension
- Tablets
ASPH
RSCH
SASH
SABP
Primary Care
Important
Tablets and oral suspension are NOT bioequivalent. Do not confuse with mercaptamine (similar name).
01.05.03
Red
Formulations :
- Infusion
- Subcutaneous injection (sc)
ASPH
RSCH
SASH
SABP
Primary Care
Important
Not 1st line.
Only in patients where steroids and/or TNF inhibitor not effective / appropriate
Non Formulary
Formulations :
- Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
For information about the icons and status values within this site, please refer to the keys below.
Icon/Links Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq form to be completed
NICE
Traffic Light Status Key
Red
Amber
Green
Black
Amber Star
Green (see narrative)
Non Formulary
See Below
N/A
Blue
Green - Black
See narrative
Do not initiate in new patients